Enlite® Sensor

Experience our breakthrough glucose sensor designed for comfort and performance.

Learn More about Continuous Glucose Monitoring
Enlite Sensor

Better Protection with Enlite5

More comfortable and accurate than ever before, our new sensor gives you better protection from dangerous highs and lows.5

Improved Performance:

  • When used with the MiniMed 530G® system, Enlite features a 93% hypo detection rate1
  • A 31% improvement in overall accuracy versus Sof-sensor® glucose sensors2
Better Protection with Enlite
1Enlite Sensor 2MiniLink REAL-Time
3Enlite Serter

So Small Users Hardly Notice It's There3

Now featuring a smaller, more flexible sensor and a virtualy pain free insertion.

Greater Comfort:

  • 85% said Enlite was comfortable under the skin3
  • 69% less sensor volume4
  • 38% shorter sensor under the skin4

  1. Enlite Sensor
  2. MiniLink® REAL-Time Transmitter
  3. Enlite Serter
So Small You’ll Hardly Notice It

Featuring a new, easier insertion process

Inserting the Enlite sensor is more comfortable and easier than ever.

Easier Insertion:

  • 75% said insertion device was easy to use3
  • Completely hidden needle
  • 90 degree insertion angle
Enlite Serter - Silver Winner, International Design Excellence Awards 2012

Try the MiniMed 530G System on for Size

Get Started Now >
    • * ...that is approved by the United States Food and Drug Administration. Medtronic has a similar product already approved in Europe.
    • 1 Enlite® Performance for the MiniMed 530G Insulin Pump. Sensor calibrated 3-4 times daily; within 30 minutes of event, both Low Glucose Limit and Low Predictive alerts ON; with 33% false alert rate if the patient is unable to respond to the Threshold Suspend alarm.
    • 2 Enlite® Performance for the MiniMed 530G Insulin Pump. MiniMed Paradigm REAL-Time Revel System Insulin Pump User Guide.
    • 3 U.S. Enlite Clinical Study Customer Satisfaction Survey. Data on file, Medtronic MiniMed, Inc., Northridge CA.
    • 4 Data on file, Medtronic MiniMed, Inc., Northridge CA.
    • 5 Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia. 2012;55:3155-3162.